Document:

Exhibit
      10.14

    

    NEITHER
      THIS SECURITY NOR THE SECURITY INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE
      BEEN
      REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
      COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
      THE SECURITIES ACT OF 1933, AS AMENDED, AND, ACCORDINGLY, MAY NOT BE OFFERED
      OR
      SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
      ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
      TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
      TO
      THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
      ACCEPTABLE TO THE COMPANY.

    

    SECURED
      CONVERTIBLE PROMISSORY NOTE

    

      
        	
                $_________

              	
                ________,
                  20__

              

      

    

    

    FOR
      VALUE
      RECEIVED, DRTATTOFF, LLC, a California limited liability company located at
      8447
      Wilshire Boulevard, Suite 102, Beverly Hills CA 90211 (the “Borrower”)
      hereby
      promises to pay to the order of _________________ (the “Holder”),
      the
      principal sum of _________________ Dollars ($_________), upon the following
      terms: 

    

    1. Security.
      This
      Note is secured as set forth in the Pledge and Security Agreement of even date
      herewith.

    

    2. Interest
      Rate.
      Interest shall accrue on the unpaid principal balance of this Note from the
      date
      of issuance until paid or converted in full at the rate of ten percent (10%)
      per
      year, calculated on a 365/366 day year, as applicable, provided, however, that
      upon an Event of Default, interest shall accrue as provided in Section 8 hereof.
      

    

    3.
       Payment
      Terms.
      The
      Borrower agrees to pay the unpaid principal balance of this Note and all accrued
      and unpaid interest on the date that is the earlier of (i) six months from
      the
      date of issuance, or (ii) five (5) business days from the date of closing by
      Borrower of equity financing in the aggregate of not less than $5.0 million
      (the
“Maturity
      Date”),
      unless previously converted in accordance with Section 5 hereof. Borrower may
      prepay all or any part of interest or principal at any time without
      penalty.

    

    4. Manner
      and Place of Payment; Holidays.
      All
      payments on this Note shall be made in coin or currency which, at the time
      or
      times of payment, constitute legal tender for public or private debts in the
      United States of America. All payments on this Note shall be made to Holder
      at
      the address stated above, or at such other address as Holder shall designate
      in
      writing. If the prescribed date of payment of any of the principal or interest
      hereon is a Saturday, Sunday or legal holiday, such payment shall be due on
      the
      next succeeding business day. 

    

    
      
        
           

        

        
           

          
            

          

        

        
           

        

      

    

    

    5. Conversion
      Rights. 

    

    (i) Conversion.
      The
      Holder, at its option, so long as any portion of this Note remains outstanding,
      may elect to convert any outstanding and unpaid principal portion of this Note,
      and any accrued and unpaid interest (the date of giving of such notice of
      conversion being a “Conversion
      Date”)
      into
      units of membership interests of the Company (“Units”)
      as
      such interests exist on the date of issuance of this Note, or any shares of
      capital stock or securities of Borrower into which such Units shall hereafter
      be
      changed or reclassified, at the conversion price as defined in Section 5(ii)
      hereof (the “Conversion
      Price”),
      determined as provided herein. Upon delivery to the Borrower of a completed
      Notice of Conversion, a form of which is annexed hereto, Borrower shall issue
      and deliver to the Holder within three (3) business days after the Conversion
      Date (such third day being the “Delivery
      Date”)
      a
      certificate evidencing the Units issuable for the portion of the Note converted
      in accordance with the foregoing. The Units issuable upon conversion of this
      Note shall be determined by dividing that portion of the principal of the Note
      and interest, if any, to be converted, by the Conversion Price. On the
      Conversion Date any and all obligations of the Borrower with respect to the
      portion of the Note so converted shall be deemed satisfied, and the Borrower
      will have no further obligation under the Note with respect to such converted
      portion in any way other than to issue the Units and Warrants (as set forth
      in
      Section 6 below).

    

    (ii) Conversion
      Price.
      Subject
      to adjustment as provided in Section 5(iii) hereof, the Conversion Price per
      Unit shall be $1.00. Fractional Units will not be issued and will instead be
      rounded up to the nearest whole Unit.

    

    (iii)  Adjustment.
      The
      Conversion Price and number and kind of shares or other securities to be issued
      upon conversion determined pursuant to Section 5(i), shall be subject to
      adjustment from time to time upon the happening of certain events while this
      conversion right remains outstanding, as follows:

    

    A. Merger,
      Sale of Assets, etc.
      If the
      Borrower at any time shall consolidate with or merge into or sell or convey
      all
      or substantially all its assets to any other corporation, this Note, as to
      the
      unpaid principal portion thereof and accrued interest thereon, shall thereafter
      be deemed to evidence the right to purchase such number and kind of shares
      or
      other securities and property as would have been issuable or distributable
      on
      account of such consolidation, merger, sale or conveyance, upon or with respect
      to the securities subject to the conversion or purchase right immediately prior
      to such consolidation, merger, sale or conveyance. The foregoing provision
      shall
      similarly apply to successive transactions of a similar nature by any such
      successor or purchaser.

    

    B. Reclassification,
      etc.
      If the
      Borrower at any time shall, by reclassification or otherwise, change the Units
      into the same or a different number of securities of any class or classes that
      may be issued or outstanding, this Note, as to the unpaid principal portion
      thereof and accrued interest thereon, shall thereafter be deemed to evidence
      the
      right to purchase an adjusted number of such securities and kind of securities
      as would have been issuable as the result of such change with respect to the
      Units issuable immediately prior to such reclassification or other
      change.

    

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    C. Splits,
      Combinations and Dividends.
      If the
      Units are subdivided or combined into a greater or smaller number of Units,
      or
      if a dividend is paid on the Units in the form of additional Units, the
      Conversion Price shall be proportionately reduced in case of subdivision of
      Units or Unit dividend or proportionately increased in the case of combination
      of Units, in each such case by the ratio which the total number of Units
      outstanding immediately after such event bears to the total number of Units
      outstanding immediately prior to such event.

     

    (iv) Method
      of Conversion.
      This
      Note may be converted by the Holder in whole or in part as described in Section
      5(i) hereof. Upon partial conversion of this Note, a new Note containing the
      same date and provisions of this Note shall, at the request of the Holder,
      be
      issued by the Borrower to the Holder for the principal balance of this Note
      and
      interest which shall not have been converted or paid.

    

    (v) Registration
      Rights.
      The
      Holder is entitled to the registration rights set forth in Annex
      A
      attached
      hereto and made a part hereof.

    

    6. Warrant
      Coverage.
      

    

    (i) Upon
      Conversion.
      In the
      event this Note is converted, in whole or in part, in the manner set forth
      in
      Section 5 herein, then Holder shall also receive at the time of conversion
      a
      Unit purchase warrant (“Warrant”)
      to
      purchase 1⁄2 Unit, or the equivalent thereof, at an exercise price of $1.00 per
      Unit, subject to adjustment in accordance with the Warrant agreement, for each
      Unit issued upon conversion of the Note. 

    

    (ii)
       At
      Maturity.
      In the
      event all or a portion of this Note remains outstanding on the Maturity Date,
      then Holder shall receive on such date a Warrant to purchase one (1) Unit,
      or
      the equivalent thereof, at an exercise price of $1.00 per Unit, for each Unit
      which would have been issued had the principal balance and accrued and unpaid
      interest outstanding on the Maturity Date been converted in accordance with
      Section 5 herein. 

    

    (iii)
       Expiration
      Date.
      All
      Warrants will expire five years from the date of this Note.

    

    7. Events
      of Default and Acceleration.
      Time is
      of the essence of this Note. The occurrence of any of the following events
      shall
      constitute an “Event
      of Default”
      hereunder: (i) Borrower's failure to pay timely any amount due hereunder, and
      such failure continues for ten (10) business days; (ii) bankruptcy,
      reorganization, insolvency or liquidation proceedings or other proceedings
      for
      relief under any bankruptcy law or any law for the relief of debtors shall
      be
      instituted by or against Borrower and, if instituted against Borrower, Borrower
      shall by any action or answer approve of, consent to or acquiesce in any such
      proceedings or admit the material allegations of, or default in answering a
      petition filed in any such proceeding or such proceedings shall not be dismissed
      within ninety (90) calendar days thereafter; (iii) any material breach by
      Borrower, that remains uncured for greater than 5 days after receipt of written
      notice of same, of any of the terms of this Note (other than payment
      obligations) or the Warrants issued by Borrower in connection with this Note;
      (iv) dissolution of the Borrower; or (v) cessation or liquidation of the
      Borrower's business or suspension of the Borrower's business for more than
      forty-five consecutive days. If any such Event of Default occurs, Holder may,
      then or at any time thereafter, and at its option, accelerate maturity and
      cause
      the entire unpaid principal balance of this Note, together with interest accrued
      hereon, to become immediately due and payable. If Holder waives Holder's right
      to accelerate maturity as a result of an Event of Default hereunder, either
      one
      or more times or repeatedly, nevertheless Holder shall not be deemed to have
      waived the right to require strict compliance with the terms of this Note
      thereafter.

    

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    8. Interest
      After Event of Default, Acceleration or Maturity.
      Upon an
      occurrence of an Event of Default hereunder, the entire unpaid balance of said
      principal sum and interest then accrued shall bear interest, while such Event
      of
      Default continues both before and after judgment, at ten percent (10%) per
      year
      on the unpaid balance until paid, calculated on a 365/366 day year, as
      applicable.

    

    9. Application
      of Payments.
      All
      sums paid hereon shall be applied first to the payment of accrued interest
      due
      on the unpaid principal balance and the remainder to the reduction of unpaid
      principal.

    

    10. Attorney's
      Fees and Expenses.
      In the
      event that Holder or other holder of this Note brings suit hereon, or employs
      an
      attorney or incurs expenses to compel payment of this Note or any portion of
      the
      indebtedness evidenced hereby, or to cure any Event of Default under this Note,
      whether through suit, probate, insolvency, reorganization, bankruptcy or any
      other legal or informal proceeding, the Borrower and all endorsers, guarantors
      and sureties agree additionally to pay all reasonable attorney's fees, court
      costs and other reasonable expenses thereby incurred by Holder or other holder
      of this Note. 

    

    11. Waiver.
      Except
      as may be required by law, Borrower and all guarantors of this Note, both before
      and after maturity, hereby expressly (i) waive all protest, notice of protest,
      demand for payment, presentment for payment, notice of intention to accelerate
      maturity, notice of acceleration of maturity, notice of dishonor, bringing
      of
      suit, and diligence in taking any action to collect any amounts called for
      hereunder and in the handling of properties, rights or collateral at any time
      existing in connection herewith; (ii) consent to and waive notice of any one
      or
      more renewal, extension or modification of this Note, whether made to or in
      favor of the Borrower or any other person or persons, regardless whether such
      renewal, extension or modification modifies the terms, interest rate or time
      for
      payment of the Note and regardless of the length of term of the renewal,
      extension or modification; (iii) consent to and waive notice of any
      substitution, exchange or release of any security hereafter given for this
      Note;
      (iv) consent to and waive notice of the release of any party primarily or
      secondarily liable hereon; (v) consent to and waive notice of any other
      indulgences, none of which shall otherwise affect the liability of any of said
      parties for the indebtedness evidenced by this Note; and (vi) agree that it
      will
      not be necessary for Holder, in order to enforce payment of this Note, first
      to
      institute suit against or to exhaust Holder's remedies against Borrower or
      any
      other party liable hereunder, or to proceed against any other security for
      this
      Note.

    

    12. Parties
      in Interest.
      This
      Note may be assigned by Holder at any time upon notice to and with written
      consent of Borrower. This Note may not be assigned by Borrower without the
      prior
      written consent of Holder. This Note will be binding in all respects upon
      Borrower and inure to the benefit of Holder and its permitted successors and
      assigns.

    

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    13. Definitions.
      The
      terms "Borrower" and "Holder" and other nouns and pronouns include the singular
      and/or the plural, as appropriate. The terms "Borrower" and "Holder" also
      include their respective heirs, personal representatives, permitted successors
      and assigns. The term "Holder" includes subsequent permitted holders of this
      Note. 

    

    14. Choice
      of Law; Venue.
      All
      questions concerning the construction, validity, enforcement and interpretation
      of this Note shall be governed by and construed and enforced in accordance
      with
      the laws of the State of California, without regard to the principles of
      conflicts of law thereof. Each party agrees that all proceedings concerning
      the
      interpretations, enforcement and defense of the transactions contemplated by
      this Note (whether brought against a party hereto or its respective affiliates,
      directors, officers, shareholders, employees or agents) shall be commenced
      exclusively in the state and federal courts of California. Each party hereto
      hereby irrevocably submits to the exclusive jurisdiction of the state and
      federal courts of California for the adjudication of any dispute hereunder
      or in
      connection herewith or with any transaction contemplated hereby or discussed
      herein, and hereby irrevocably waives, and agrees not to assert in any
      proceeding, any claim that it is not personally subject to the jurisdiction
      of
      any such court, that such proceeding is improper. The parties hereto hereby
      irrevocably waive, to the fullest extent permitted by applicable law, any and
      all right to trial by jury in any legal proceeding arising out of or relating
      to
      this Note or the transactions contemplated hereby. Neither party shall be
      entitled to injunctive relief to prevent or cure breaches of the provisions
      of
      this Note. If any party shall commence a proceeding to enforce any provisions
      of
      this Note, then the prevailing party in such proceeding shall be reimbursed
      by
      the other party for its reasonable attorneys fees and other costs and expenses
      incurred with the investigation, preparation and prosecution of such
      proceeding.

    

    15. Notice.
      All
      notices and other communications required or permitted hereunder shall be in
      writing and shall be deemed to have been duly given one (1) business day after
      delivery to an overnight carrier with instructions to deliver to the applicable
      address set forth above, or, if sent by facsimile, upon receipt of a
      confirmation of delivery.

    

    16. Severability.
      If any
      part of this Note is adjudged illegal, invalid or unenforceable, such invalidity
      or unenforceability shall not affect any other provision of this Note that
      can
      be given effect without such provision.

    

    17. Amendments.
      This
      Note may not be varied, amended or modified except in writing signed by the
      Borrower and the Holder.

    

    18. Member
      Status.
      The
      Holder shall not have rights as a member of the Borrower with respect to
      unconverted portions of this Note. However, the Holder will have all the rights
      of a member of the Borrower with respect to the Units to be received by Holder
      after delivery by the Holder of a Conversion Notice to the
      Borrower.

    

    THIS
      NOTE REPRESENTS THE FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE
      CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS OR SUBSEQUENT ORAL AGREEMENTS
      OF THE PARTIES.

    

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

    THERE
      ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES.

    

    IN
      WITNESS WHEREOF, Borrower has executed this Note effective as of the date first
      set forth above.

    

    
      	
              BORROWER:

            
	 	 
	
              By:
                

            	 
	
              Name:

            	
              James
                Morel

            
	
              Its:

            	
              Chief
                Executive Officer

            

    

     

    
      
        
           

        

        
          6

          
            

          

        

        
           

        

      

    

     

    
      Exhibit
        10.14

       

    

    NOTICE
      OF CONVERSION

    

    (To
      be
      executed and delivered by the Holder in order to convert the Note)

     

    The
      undersigned hereby elects to convert $_________ of the principal and $_________
      of the interest due on the Note issued by DRTATTOFF, LLC (the “Borrower”)
      on
      ______________, 20___ into Units of the Borrower according to the conditions
      set
      forth in such Note, as of the date written below.

    

    Date
      of
      Conversion:________________________________________________________________________________

    

    Conversion
      Price:__________________________________________________________________________________

    

    Units
      To
      Be
      Issued:________________________________________________________________________________

    

    Signature:________________________________________________________________________________________

     

    Print
      Name:_______________________________________________________________________________________

     

    Address:________________________________________________________________________________________

    

    _______________________________________________________________________________________________

    

    
      
        
           

        

        
           

          
            

          

        

        
           

        

      

    

     

    Exhibit
      10.14

    ANNEX
      A

    

    REGISTRATION
      RIGHTS

     

    1. DEFINITIONS.
      Capitalized terms used and not otherwise defined herein that are defined in
      the
      Note shall have the meanings given such terms in the Note. As used herein,
      the
      following terms shall have the following meanings:

     

    “Commission”
means
      the Securities and Exchange Commission.

     

    “Exchange
      Act”
means
      the Securities Exchange Act of 1934, as amended, and any successor
      statute.

     

    “Holder”
or
      “Holders”
means
      the Note Holder or Holders to the extent any of them hold Registrable
      Securities.

     

    “Indemnified
      Party”
shall
      have the meaning set forth in Section 5.2.

     

    “Indemnifying
      Party”
shall
      have the meaning set forth in Section 5.2.

     

    “Piggy-Back
      Registration”
is
      defined in Section 2.1.

     

    “Proceeding”
means
      an action, claim, suit, investigation or proceeding (including, without
      limitation, an investigation or partial proceeding, such as a deposition),
      whether commenced or threatened. 

     

    “Prospectus”
means
      the prospectus included in the Registration Statement (including, without
      limitation, a prospectus that includes any information previously omitted from
      a
      prospectus filed as part of an effective registration statement in reliance
      upon
      Rule 430A promulgated under the Securities Act), as amended or supplemented
      by
      any prospectus supplement, with respect to the terms of the offering of any
      portion of the Registrable Securities covered by the Registration Statement,
      and
      all other amendments and supplements to the Prospectus, including post-effective
      amendments, and all material incorporated by reference or deemed to be
      incorporated by reference in such Prospectus. 

     

    “Registrable
      Securities”
means
      the membership interests issuable upon conversion of the Note, or other
      securities of the Company or any other issuer or issuable in respect of such
      Units (because of stock splits, stock dividends, reclassifications,
      recapitalizations, mergers, combinations or similar events, if applicable);
      provided, however, that the Units which are Registrable Securities shall cease
      to be Registrable Securities upon any sale or transfer of such securities
      pursuant to a Registration Statement, Section 4(1) of the Securities Act, Rule
      144 under the Securities Act or otherwise.

     

    “Registration
      Statement”
means
      a
      registration statement filed by the Company with the Commission on any
      registration form prescribed by the Commission permitting a secondary offering
      or distribution, other than on Form S-4, Form S-8 or similar forms.

     

    
      
         

      

      
        A-1

        
          

        

      

      
         

      

    

     

    “Rule
      144”
means
      Rule 144 promulgated by the Commission pursuant to the Securities Act, as such
      Rule may be amended from time to time, or any similar rule or regulation
      hereafter adopted by the Commission having substantially the same effect as
      such
      Rule. 

     

    “Securities
      Act”
means
      the Securities Act of 1933, as amended, and any successor statute.

     

    “Trading
      Market”
means
      any of the Pink Sheets LLC electronic quotation service, NASD OTC Bulletin
      Board, NASDAQ Global Select Market, NASDAQ Global Market, NASDAQ Capital Market,
      American Stock Exchange or the New York Stock Exchange.

     

    “Note”
means
      the Convertible Promissory Note issued by the Company.

     

    2. PIGGY-BACK
      REGISTRATION.

     

    2.1 At
      any
      time and from time to time while any portion of the Note remains outstanding,
      whenever the Company proposes to file a Registration Statement, the Company
      will
      prior to such filing give written notice to Holder of its intention to do so
      and, upon the written request of Holder given within ten (10) days after the
      Company provides such notice, the Company shall use its good faith efforts
      to
      cause all Registrable Securities which the Company has been requested by Holder
      to register to be registered under the Securities Act to the extent necessary
      to
      permit their sale or other disposition in accordance with the intended methods
      of distribution specified in the request of Holder; provided that the Company
      shall have the right to postpone or withdraw any registration effected pursuant
      to this Section 2 without obligation or liability to Holder. In the Holder’s
      request, the Holder will be required to describe briefly its proposed
      disposition of the Registrable Securities. However, in connection with any
      registration under Section 2, the Holder’s Registrable Securities shall be
      junior and subordinate to any registration rights granted by the Company which
      are already outstanding, and any senior registration rights granted by the
      Company in the future. 

     

    2.2 In
      connection with any registration under Section 2 involving an underwritten
      offering of the Company’s securities, the Company shall not be required to
      include any Registrable Securities in such underwriting unless Holder accepts
      the terms of the underwriting as agreed upon between the Company and the
      underwriters selected by it, and then only in such quantity as will not, in
      the
      sole discretion of the underwriters, jeopardize the success of the offering
      by
      the Company. If in the sole discretion of the managing underwriter or
      underwriters the registration of all, or part of, the Registrable Securities
      which Holder has requested to be included would adversely affect such public
      offering, then the Company shall be required to include in the underwriting
      only
      that number of Registrable Securities, if any, which the managing underwriter
      or
      underwriters believe may be sold without causing such adverse effect. If the
      number of Registrable Securities to be included in the underwriting in
      accordance with the foregoing is less than the total number of Registrable
      Securities which Holder has requested to be included, then Holder and each
      participant other than the Company in such underwriting shall participate in
      the
      underwriting pro rata based upon their total ownership of Registrable
      Securities. Any such limitation shall be imposed in such manner so as to avoid
      any diminution in the number of securities the Company may register for sale
      by
      giving first priority for the securities to be registered for issuance and
      sale
      by the Company and the underwriter, and by giving second priority for the
      securities to be registered for sale by any holder of Registrable Securities
      pursuant to the terms of this Agreement.

     

    
      
         

      

      
        A-2

        
          

        

      

      
         

      

    

     

    2.3 In
      connection with any registration under this Section 2 involving a selling
      stockholder registration statement or any other registration statement not
      involving an underwritten offering of the Company’s securities, the Company
      reserves the right to include only that number of Registrable Securities, if
      any, as it shall determine in its sole discretion, may be sold without
      jeopardizing the success of the offering or having an adverse effect on the
      offering. If the number of Registrable Securities to be included in the offering
      in accordance with the foregoing is less than the total number of Registrable
      Securities which Holder has requested to be included, then Holder and each
      participant other than the Company in such offering shall participate in the
      offering pro rata based upon their total ownership of Registrable Securities.
      Any such limitation shall be imposed in such manner so as to avoid any
      diminution in the number of securities the Company may register for sale by
      giving first priority for the securities to be registered for issuance and
      sale
      by the Company, and by giving second priority for the securities to be
      registered for sale by any holder of Registrable Securities pursuant to the
      terms of this Agreement.

     

    2.4
       Any
      holder of Registrable Securities may elect to withdraw such holder’s request for
      inclusion of Registrable Securities in any Piggy-Back Registration by giving
      written notice to the Company of such request to withdraw prior to the
      effectiveness of the Registration Statement. The Company may also elect to
      withdraw a registration statement at any time prior to the effectiveness of
      the
      Registration Statement. Notwithstanding any such withdrawal, the Company shall
      pay all expenses incurred by the holders of Registrable Securities in connection
      with such Piggy-Back Registration as provided in Section 4 hereof.

     

    3.  REGISTRATION
      PROCEDURES.
      When
      the Company proposes to effect the registration of any of the Registrable
      Securities under the Securities Act, the Company shall: 

     

    3.1 furnish
      to the Holder such number of copies of the Registration Statement and the
      Prospectus included therein (including each preliminary Prospectus) as the
      Holder reasonably may request to facilitate the public sale or disposition
      of
      the Registrable Securities covered by the Registration Statement;

     

    3.2 use
      its
      commercially reasonable efforts to register or qualify the Holder’s Registrable
      Securities covered by the Registration Statement under the securities or “blue
      sky” laws of such jurisdictions within the United States as the Holder may
      reasonably request, provided, however, that the Company shall not for any such
      purpose be required to qualify generally to transact business as a foreign
      corporation in any jurisdiction where it is not so qualified or to consent
      to
      general service of process in any such jurisdiction; and

     

    3.3 list
      the
      Registrable Securities covered by the Registration Statement with any Trading
      Market on which the equity securities of the Company is then listed.

     

    
      
         

      

      
        A-3

        
          

        

      

      
         

      

    

     

    4. REGISTRATION
      EXPENSES.
      All
      expenses relating to the Company’s compliance with Sections 2 and 3 hereof,
      including, without limitation, all registration and filing fees, printing
      expenses, fees and disbursements of counsel and independent public accountants
      for the Company, fees and expenses (including reasonable counsel fees) incurred
      in connection with complying with state securities or “blue sky” laws, fees of
      the NASD, transfer taxes, fees of transfer agents and registrars are called
      “Registration Expenses.” All selling commissions applicable to the sale of
      Registrable Securities, including any fees and disbursements of any counsel
      to
      the Holders, are called “Selling Expenses” and shall be the responsibility of
      the Holder. The Company shall only be responsible for all Registration
      Expenses.

     

    5. INDEMNIFICATION.

     

    5.1 In
      the
      event of a registration of the Registrable Securities, the Holder (subject
      to
      the provisions of Section 5.2) will indemnify and hold harmless the Company
      or
      its successor, and its officers, directors and each other person, if any, who
      controls the Company within the meaning of the Securities Act, against all
      losses, claims, damages or liabilities, joint or several, to which the Company
      or such persons may become subject under the Securities Act, the Exchange Act or
      otherwise, insofar as such losses, claims, damages or liabilities (or actions
      in
      respect thereof) arise out of or are based upon: (i) any untrue statement
      or alleged untrue statement of any material fact which was furnished in writing
      by the Holder to the Company expressly for use in (and such information is
      contained in) the Registration Statement under which such Registrable Securities
      were registered under the Securities Act pursuant to the Note, any preliminary
      Prospectus or final Prospectus contained therein, or any amendment or supplement
      thereof, or arise out of or are based upon the omission or alleged omission
      to
      state therein a material fact required to be stated therein or necessary to
      make
      the statements therein not misleading, and will reimburse the Company and each
      such person for any reasonable legal or other expenses incurred by them in
      connection with investigating or defending any such loss, claim, damage,
      liability or action, provided, however, that such Holder will be liable in
      any
      such case if and only to the extent that any such loss, claim, damage or
      liability arises out of or is based upon said Holder’s untrue statement or
      alleged untrue statement or omission or alleged omission so made in conformity
      with information furnished in writing to the Company by or on behalf of said
      Holder specifically for use in any such document, or (ii) in connection
      with a Holder’s sale of Registrable Securities, including without limitation
      alleged violations of Regulation M. Notwithstanding the provisions of this
      paragraph, no Holder shall be required to indemnify any person or entity in
      excess of the amount of the aggregate net proceeds received by said Holder
      in
      respect of Registrable Securities in connection with any such registration
      under
      the Securities Act.

     

    
      
         

      

      
        A-4

        
          

        

      

      
         

      

    

     

    5.2 Promptly
      after receipt by a party entitled to claim indemnification hereunder (an
“Indemnified Party”) of notice of the commencement of any action, such
      Indemnified Party shall, if a claim for indemnification in respect thereof
      is to
      be made against a party hereto obligated to indemnify such Indemnified Party
      (an
“Indemnifying Party”), notify the Indemnifying Party in writing thereof, but the
      omission so to notify the Indemnifying Party shall not relieve it from any
      liability which it may have to such Indemnified Party other than under this
      Section 5.2 and shall only relieve it from any liability which it may have
      to
      such Indemnified Party under this Section 5.2 if and to the extent the
      Indemnifying Party is prejudiced by such omission. In case any such action
      shall
      be brought against any Indemnified Party and it shall notify the Indemnifying
      Party of the commencement thereof, the Indemnifying Party shall be entitled
      to
      participate in and, to the extent it shall wish, to assume and undertake the
      defense thereof with counsel reasonably satisfactory to such Indemnified Party,
      and, after notice from the Indemnifying Party to such Indemnified Party of
      its
      election so to assume and undertake the defense thereof, the Indemnifying Party
      shall not be liable to such Indemnified Party under this Section 5.2 for any
      legal expenses subsequently incurred by such Indemnified Party in connection
      with the defense thereof; if the Indemnified Party retains its own counsel,
      then
      the Indemnified Party shall pay all fees, costs and expenses of such counsel,
      provided, however, that, if the defendants in any such action include both
      the
      Indemnified Party and the Indemnifying Party and if counsel shall have
      reasonably concluded that there may be reasonable defenses available to the
      Indemnified Party which are different from or additional to those available
      to
      the Indemnifying Party or if the interests of the Indemnified Party reasonably
      may be deemed to conflict with the interests of the Indemnifying Party in either
      case which would prohibit such counsel from representing both parties under
      applicable conflicts of interest rules of professional ethics, the Indemnified
      Party shall have the right to select one separate counsel and to assume such
      legal defenses and otherwise to participate in the defense of such action,
      with
      the reasonable expenses and fees of such separate counsel and other expenses
      related to such participation to be reimbursed by the Indemnifying Party as
      incurred. Neither party shall settle any proceeding for which indemnification
      is
      sought without the written consent of the other party, which shall not be
      unreasonably withheld.

     

    5.3
       Notwithstanding
      any provision herein to the contrary, each Holder shall be treated individually
      and separately from all other Holders under this Section 5, and will not become
      the subject of any obligation under this Section 5 as a result of any action,
      failure to act, statement, omission, or otherwise of any other Holder
      hereunder.

     

    
      
         

      

      
        A-5Exhibit
      10.15

    NEITHER
      THIS SECURITY NOR THE SECURITY INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
      BEEN
      REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
      COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
      THE SECURITIES ACT OF 1933, AS AMENDED, AND, ACCORDINGLY, MAY NOT BE OFFERED
      OR
      SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
      ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
      TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
      TO
      THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
      ACCEPTABLE TO THE COMPANY.

    

    

    Warrant
      No. W-_________

    

    

    Void
      after 5:00 p.m., Eastern Standard Time on ___________, 20_____

    

    COMMON
      STOCK PURCHASE WARRANT

    

    

    Lifesciences
      Opportunities Incorporated, a Florida corporation (the “Company”),
      hereby certifies that, for value received,
      ______________________,
      located at __________________  (the
      “Warrant
      Holder”)
      is the
      owner of the number of common stock purchase warrants (“Warrants”)
      which
      entitles the holder thereof to purchase, at any time during the period
      commencing on the Commencement Date (as defined herein) and ending on the
      Expiration Date (as defined herein), ____________ (_____) fully paid and
      non-assessable shares of common stock, par value $.0001 per share (“Common
      Stock”),
      of
      the Company at a purchase price equal to the Exercise Price (as defined below)
      in lawful money of the United States of America in cash, subject to adjustment
      as hereinafter provided. 

    

    1. WARRANT;
      EXERCISE PRICE.

    

    1.1 This
      Warrant is issued pursuant to a Subscription Agreement dated as of the date
      hereof, by and among the Company and the Warrant Holder (the “Subscription
      Agreement”).
      

    

    1.2 Each
      Warrant shall entitle the Warrant Holder to purchase one share of Common Stock
      (individually, a “Warrant
      Share”
      severally, the “Warrant
      Shares”).
      

    

    1.3 The
      purchase price payable upon exercise of each Warrant (the “Exercise
      Price”)
      shall
      be $1.00 per Warrant Share. Notwithstanding the foregoing, the Exercise Price
      and number of Warrant Shares purchasable pursuant to each Warrant are subject
      to
      adjustment as provided in Section 8. 

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    2. EXERCISE
      OF WARRANT; EXPIRATION DATE.
      

    

    2.1 This
      Warrant is exercisable at any time and from time to time commencing the date
      hereof (“Commencement
      Date”)
      and
      ending at 5:00 p.m., Eastern Time on ___________, 20____ (the “Expiration
      Date”),
      in
      whole or from time to time in part, at the option of the Warrant Holder, upon
      surrender of this Warrant to the Company together with a duly completed Notice
      of Exercise in the form attached hereto and payment of an amount equal to the
      then applicable Exercise Price multiplied by the number of Warrant Shares then
      being purchased upon such exercise. 

    

    2.2 Each
      exercise of this Warrant shall be deemed to have been effected immediately
      prior
      to the close of business on the day on which this Warrant shall have been
      surrendered to the Company as provided in Section 2.1. At such time, the person
      or persons in whose name or names any certificates for Warrant Shares shall
      be
      issuable upon such exercise as provided in Section 2.3 below shall be deemed
      to
      have become the holder or holders of record of the Warrant Shares represented
      by
      such certificates.

    

    2.3 Within
      five business days after the exercise of the purchase right represented by
      this
      Warrant, the Company at its expense will use its reasonable best efforts to
      cause to be issued in the name of, and delivered to, the Warrant Holder, or,
      subject to the terms and conditions hereof, to such other individual or entity
      as such Warrant Holder (upon payment by such Warrant Holder of any applicable
      transfer taxes) may direct: 

    

    (a) a
      certificate or certificates for the number of full Warrant Shares to which
      such
      Warrant Holder shall be entitled upon such exercise, and 

    

    (b) in
      case
      such exercise is in part only, a new Warrant or Warrants (dated the date hereof)
      of like tenor, stating on the face or faces thereof the number of Warrant Shares
      currently stated on the face of this Warrant minus the number of such Warrant
      Shares purchased by the Warrant Holder upon such exercise as provided in Section
      2.2 (in each case prior to any adjustments made thereto pursuant to the
      provisions of this Warrant).

    

    3. REGISTRATION
      AND TRANSFER ON COMPANY BOOKS.
      

    

    3.1 The
      Company (or an agent of the Company) will maintain a register containing the
      names and addresses of the Warrant Holders. Any Warrant Holder may change its,
      his or her address as shown on the Warrant register by written notice to the
      Company requesting such change. 

    

    3.2 The
      Company shall register upon its books any transfer of a Warrant upon surrender
      of same as provided in Section 5. 

    

    4. RESERVATION
      OF WARRANT SHARES.
      The
      Company will at all times reserve and keep available, solely for issuance and
      delivery upon the exercise of this Warrant, such Warrant Shares and other stock,
      securities and property, as from time to time shall be issuable upon the
      exercise of this Warrant. 

    

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    5. EXCHANGE,
      TRANSFER, ASSIGNMENT OR LOSS OR MUTILATION OF WARRANTS.
      This
      Warrant is exchangeable, without expense, at the option of the Warrant Holder,
      upon presentation and surrender hereof to the Company for other warrants of
      different denominations entitling the holder thereof to purchase in the
      aggregate the same number of Warrant Shares purchasable hereunder. Subject
      to
      the terms of Sections 6 and 7, upon surrender of this Warrant to the Company
      at
      its principal office or at the office of its transfer agent, if any, with the
      Assignment Form annexed hereto duly executed and funds sufficient to pay any
      transfer tax, the Company shall, without charge, execute and deliver a new
      Warrant in the name of the assignee named in such instrument of assignment
      and
      this Warrant shall be promptly canceled. Subject to the terms of Sections 6
      and
      7, this Warrant may be divided or combined with other Warrants which carry
      the
      same rights upon presentation hereof at the principal office of the Company
      together with a written notice specifying the names and denominations in which
      new Warrants are to be issued and signed by the Warrant Holder hereof. The
      term
“Warrant” as used herein includes any Warrants into which this Warrant may be
      divided or exchanged. Upon receipt by the Company of reasonable evidence of
      the
      ownership of and the loss, theft, destruction or mutilation of this Warrant
      and,
      in the case of loss, theft or destruction, of indemnity reasonably satisfactory
      to the Company, or, in the case of mutilation, upon surrender and cancellation
      of the mutilated Warrant, the Company shall execute and deliver in lieu thereof
      a new Warrant of like tenor and date representing an equal number of Warrants.
      

    

    6. LIMITATION
      ON EXERCISE AND SALES.
      

    

    6.1 Each
      holder of this Warrant acknowledges that this Warrant and the Warrant Shares
      have not been registered under the Securities Act, as of the date of issuance
      hereof. This Warrant may only be transferred in compliance with this Section
      6
      and Section 7. The Company shall be under no obligation to issue the Warrant
      Shares covered by such exercise unless and until the Warrant Holder shall have
      executed the form of exercise annexed hereto that states that at the time of
      such exercise that it is then an “accredited investor” within the meaning of
      Rule 501 of Regulation D, is acquiring such Warrant Shares for its own account,
      and will not transfer the Warrant Shares unless pursuant to an effective and
      current registration statement under the Securities Act or an exemption from
      the
      registration requirements of the Securities Act and any other applicable
      restrictions, in which event the Warrant Holder shall be bound by the provisions
      of a legend or legends to such effect that shall be endorsed upon the
      certificate(s) representing the Warrant Shares issued pursuant to such exercise.
      In such event, the Warrant Shares issued upon exercise hereof shall be imprinted
      with a legend in substantially the form provided in Section 7.2. 

    

    6.2 Warrant
      Holder represents and warrants that it is acquiring this Warrant for its own
      account, for purposes of investment, and not with a view to, or for sale in
      connection with, any distribution thereof within the meaning of the Securities
      Act and the rules and regulations promulgated thereunder. Warrant Holder
      represents, warrants and agrees that it will not sell, exercise, transfer or
      otherwise dispose of this Warrant (or any interest therein) or any of the
      Warrant Shares purchasable upon exercise hereof, except pursuant to (i) an
      effective registration statement under the Securities Act and applicable state
      securities laws or (ii) an opinion of counsel, satisfactory to Company, that
      an
      exemption from registration under the Securities Act and such laws is available.
      Warrant Holder further acknowledges and agrees that Company is not required,
      legally or contractually, so to register or qualify the Warrant or such Warrant
      Shares or to take any action to make such an exemption available. Warrant Holder
      understands that Company will be relying upon the truth and accuracy of the
      representations and warranties contained in this Section 6 in issuing this
      Warrant and such Warrant Shares without first registering the issuance thereof
      under the Securities Act or qualifying or registering the issuance thereof
      under
      any state securities laws that may be applicable. 

    

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    6.3 Warrant
      Holder acknowledges that (i) there is not now, and there may not be in the
      future, any public market for the Warrant or the Warrant Shares, (ii) although
      there currently is not a public trading market for the Warrant Shares, there
      can
      be no assurance that any such market will be created and sustained, and (iii)
      there can be no assurance that Warrant Holder will be able to liquidate its
      investment in Company. Warrant Holder represents and warrants that it is
      familiar with and understands the terms and conditions of Rule 144 promulgated
      under the Securities Act. 

    

    6.4 Warrant
      Holder represents and warrants to Company that (i) it has such knowledge and
      experience in financial and business matters as is necessary to enable it to
      evaluate the merits and risks of any investments in Company and is not utilizing
      any other person to be a purchaser representative in connection with evaluation
      of such merits and risks; and (ii) it has no need for liquidity in an investment
      in Company and is able to bear the risk of that investment for an indefinite
      period and to afford a complete loss thereof. 

    

    6.5 Warrant
      Holder represents and warrants that it has had access to, and has been furnished
      with, all of the information it has requested from Company and has had an
      opportunity to review the books and records of Company and to discuss with
      management and members of the board of directors of Company the business and
      financial affairs of Company. 

    

    6.6 Warrant
      Holder agrees that at the time of each exercise of this Warrant, unless the
      issuance of Warrant Shares issuable thereupon is pursuant to an effective
      registration statement under the Securities Act and under applicable state
      blue
      sky laws, Warrant Holder will provide Company with a letter embodying the
      representations and warranties set forth in Sections 6.2 through 6.5, in form
      and substance reasonably satisfactory to Company, and agrees that the
      certificate(s) representing any securities issued to it upon any exercise of
      this Warrant may bear such restrictive legend as Company may deem necessary
      to
      reflect the restricted status of such securities under the Securities Act unless
      Company shall have received from Warrant Holder an opinion of counsel to Warrant
      Holder, reasonably satisfactory in form and substance to Company and its
      counsel, that such restrictive legend is not required.

    

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    7. TRANSFER
      RESTRICTIONS.

    

    7.1 If,
      at
      the time of the surrender of this Warrant in connection with any transfer of
      this Warrant, the transfer of this Warrant shall not be registered pursuant
      to
      an effective registration statement under the Securities Act and under
      applicable state securities or blue sky laws, the Company may require, as a
      condition of allowing such transfer (i) that the Warrant Holder or transferee
      of
      this Warrant, as the case may be, furnish to the Company a written opinion
      of
      counsel (which opinion shall be in form, substance and scope customary for
      opinions of counsel in comparable transactions and reasonably satisfactory
      to
      counsel for the Company) to the effect that such transfer may be made without
      registration under the Securities Act and under applicable state securities
      or
      blue sky laws, (ii) that the holder or transferee execute and deliver to the
      Company an investment letter in form and substance acceptable to the Company,
      (iii) that transferee agree in writing with the Company to be bound by the
      terms
      and conditions of this Warrant applicable to the Warrant Holder and (iv) that
      the transferee be an “accredited investor” as defined in Regulation D
      promulgated under the Securities Act. 

    

    7.2 The
      Warrant Shares issuable on the exercise of the Warrant shall bear the following
      legend:

    

    THESE
      SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION,
      OR THE SECURITIES COMMISSION OF ANY STATE, IN RELIANCE UPON AN EXEMPTION FROM
      REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
      ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
      EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
      AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
      REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
      SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
      TO
      SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
      COMPANY.

    

    7.3 The
      Holder acknowledges that the Warrant Shares acquired upon the exercise of this
      Warrant, if not registered, will have restrictions upon resale imposed by state
      and federal securities laws.

    

    8. ADJUSTMENT
      OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES DELIVERABLE.
      The
      Exercise Price and the number of Warrant Shares purchasable pursuant to each
      Warrant shall be subject to adjustment from time to time as hereinafter set
      forth in this Section 8: 

    

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    8.1 In
      case,
      prior to the expiration of this Warrant by exercise or by its terms, the Company
      shall issue any additional shares of Common Stock as a dividend or subdivide
      the
      number of outstanding shares of Common Stock into a greater number of shares
      of
      Common Stock, then in either of such cases, the then applicable Exercise Price
      per Warrant Share purchasable pursuant to this Warrant in effect at the time
      of
      such action shall be proportionately reduced and the number of Warrant Shares
      at
      that time purchasable pursuant to this Warrant shall be proportionately
      increased; and conversely, in the event the Company shall reduce the number
      of
      outstanding shares of Common Stock by combining such shares into a smaller
      number of shares of Common Stock then, in such case, the then applicable
      Exercise Price per Warrant Share purchasable pursuant to this Warrant in effect
      at the time of such action shall be proportionately increased and the number
      of
      Warrant Shares at that time purchasable pursuant to this Warrant shall be
      proportionately decreased. 

     

    8.2 In
      case,
      prior to the expiration of this Warrant by exercise or by its terms, the Company
      shall be recapitalized by reclassifying its outstanding shares of Common Stock,
      or the Company or a successor entity (“successor
      Entity”)
      shall
      consolidate or merge with or convey all or substantially all of its or of any
      successor Entity’s property and assets to any other Entity or Entities (any such
      other Entities being included within the meaning of the term “successor Entity”
hereinbefore used in the event of any consolidation or merger of any such other
      Entity with, or the sale of all or substantially all of the property of any
      such
      other Entity to, another Entity or Entities), then, as a condition of such
      recapitalization, consolidation, merger or conveyance, lawful and adequate
      provision shall be made whereby the holder of this Warrant shall thereafter
      have
      the right to purchase, upon the same basis and on the otherwise same terms
      and
      conditions specified in this Warrant, in lieu of the Warrant Shares theretofore
      purchasable upon the exercise of this Warrant, such shares of stock, securities
      or assets, as may be issued or payable with respect to, or in exchange for,
      the
      number of Warrant Shares theretofore purchasable upon the exercise of this
      Warrant had such recapitalization, consolidation, merger, or conveyance not
      taken place, and the exercise price for which shall have been appropriately
      adjusted, if necessary, to reflect the number of securities which the Warrant
      Holder is entitled to purchase in exchange for such Warrant; and in any such
      event, the rights of the Warrant Holder to any adjustment in the number of
      Warrant Shares purchasable upon the exercise of this Warrant, as herein
      provided, shall continue and be preserved in respect of any securities which
      the
      Warrant Holder becomes entitled to purchase.

    

    8.3 In
      case
      the Company at any time while this Warrant shall remain unexpired and
      unexercised shall sell all or substantially all of its property or dissolve,
      liquidate, or wind up its affairs, lawful provision shall be made as part of
      the
      terms of any such sale, dissolution, liquidation or winding up, so that the
      holder of this Warrant may thereafter receive upon exercise hereof in lieu
      of
      each Warrant Share that it would have been entitled to receive, the same kind
      and amount of any securities or assets as may be issuable, distributable or
      payable upon any such sale, dissolution, liquidation or winding up with respect
      to each share of Common Stock of the Company, provided, however, that in any
      case of any such sale or of dissolution, liquidation or winding up, the right
      to
      exercise this Warrant shall terminate on a date fixed by the Company; such
      date
      so fixed to be not earlier than 5:00 p.m., Eastern Time, on the forty-fifth
      day
      next succeeding the date on which notice of such termination of the right to
      exercise this Warrant has been given by mail to the registered holder of this
      Warrant at its address as it appears on the books of the Company.

    

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    8.4 If
      the
      Company shall at any time prior to the expiration of this Warrant issue any
      shares of Common Stock or securities convertible into shares of Common Stock
      to
      a person other than the Warrant Holder for a consideration per share of Common
      Stock (the “Offer
      Price”),
      less
      than the Exercise Price in effect at the time of such issuance, then the
      Exercise Price shall be immediately reset to such lower Offer Price. The
      Exercise Price, as so adjusted, shall be readjusted in the same manner upon
      the
      happening of any successive event or events described herein in this Section
      8.
      Notwithstanding the foregoing, no adjustment will be made under this Section
      8.4
      in respect of any “Excluded Securities.” “Excluded
      Securities”
means
      any shares of Common Stock or Common Stock equivalents issued or issuable to
      any
      persons and entities arising from any (i) issuance of securities pursuant to
      any
      stock option or equity incentive plan of the Company, (ii) any securities issued
      in connection with the acquisition of assets, stock purchase or merger whereby
      the Company is the surviving corporation, (iii) issuance of any securities
      pursuant to any subsequent agreement between Warrant Holder or any of its
      affiliates, and the Company, and (iv) issuances of shares of Common Stock or
      other securities arising from any existing obligation of the Company prior
      to
      the date of this Warrant.

    

    No
      adjustment in the per Warrant Share Exercise Price shall be required unless
      such
      adjustment would require an increase or decrease in the Exercise Price by at
      least $0.01; provided, however, that any adjustments that by reason of this
      subsection are not required to be made shall be carried forward and taken into
      account in any subsequent adjustment. All calculations under this Section 8
      shall be made to the nearest cent or to the nearest 1/100th of a share, as
      the
      case may be.

    

    9. VOLUNTARY
      ADJUSTMENT BY THE COMPANY.
      The
      Company may, at its option, at any time during the term of the Warrants, reduce
      the then current Exercise Price to any amount deemed appropriate by the Board
      of
      Directors of the Company and/or extend the date of the expiration of the
      Warrants. 

    

    10. RIGHTS
      OF THE HOLDER.
      The
      Warrant Holder shall not, by virtue hereof, be entitled to any rights of a
      shareholder of the Company, either at law or equity, and the rights of the
      Warrant Holder are limited to those expressed in this Warrant and are not
      enforceable against the Company except to the extent set forth herein. This
      Warrant does not entitle the Holder to any voting rights or other rights as
      a
      shareholder of the Company prior to the Exercise Date and then only with respect
      to the Warrant Shares to be issued with respect thereto. 

    

    11. NOTICES
      OF RECORD DATE.
      In
      case: 

    

    11.1 the
      Company shall take a record of the holders of its shares of Common Stock (or
      other stock or securities at the time deliverable upon the exercise of this
      Warrant) for the purpose of entitling or enabling them to receive any dividend
      or other distribution, or to receive any right to subscribe for or purchase
      any
      shares of Common Stock or any other securities, or to receive any other right,
      or 

    

    11.2 of
      any
      capital reorganization of the Company, any reclassification of the equity
      capital of the Company, any consolidation or merger of the Company with or
      into
      an Entity or other entity (other than a consolidation or merger in which the
      Company is the surviving entity), or any transfer of all or substantially all
      of
      the assets of the Company, or 

    

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    11.3 of
      the
      voluntary or involuntary dissolution, liquidation or winding-up of the Company,
      

    

    then,
      and
      in each such case, the Company will mail or cause to be mailed to the Warrant
      Holder a notice specifying, as the case may be, (i) the date on which a record
      is to be taken for the purpose of such dividend, distribution or right, and
      stating the amount and character of such dividend, distribution or right, or
      (ii) the effective date on which such reorganization, reclassification,
      consolidation, merger, transfer, dissolution, liquidation or winding-up is
      to
      take place, and the time, if any is to be fixed, as of which the holders of
      record of shares of Common Stock (or such other stock or securities at the
      time
      deliverable upon the exercise of this Warrant) shall be entitled to exchange
      their shares of Common Stock (or such other stock or securities) for securities
      or other property deliverable upon such reorganization, reclassification,
      consolidation, merger, transfer, dissolution, liquidation or winding-up. Such
      notice shall be mailed at least ten days prior to the record date or effective
      date for the event specified in such notice, provided that the failure to mail
      such notice shall not affect the legality or validity of any such action.

    

    12. REGISTRATION
      RIGHTS.
      The
      Holder of this Warrant has been granted certain registration rights by the
      Company. These registration rights are set forth in a Registration Rights
      Agreement entered into by the Company and Holder dated as of even date of this
      Warrant.

    

    13. SUCCESSORS.
      The
      rights and obligations of the parties to this Warrant will inure to the benefit
      of and be binding upon the parties hereto and their respective heirs,
      successors, assigns, pledgees, transferees and purchasers. 

    

    

    14. CHANGE
      OR WAIVER.
      Any
      term of this Warrant may be changed or waived only by an instrument in writing
      signed by the party against whom enforcement of the change or waiver is sought.
      

    

    15. HEADINGS.
      The
      headings in this Warrant are for purposes of reference only and shall not limit
      or otherwise affect the meaning of any provision of this Warrant. Wherever
      possible, each provision of this Warrant shall be interpreted in such manner
      as
      to be effective and valid under applicable law, but if any provision of this
      Warrant shall be prohibited by or invalid under applicable law, such provision
      shall be ineffective to the extent of such prohibition or invalidity, without
      invalidating the remainder of such provisions or the remaining provisions of
      this Warrant.

    

    16. GOVERNING
      LAW.
      This
      Warrant shall be governed by and construed in accordance with the laws of the
      State of Florida. Any action or litigation brought by either party against
      the
      other concerning the transactions contemplated by this Warrant shall be brought
      only in the state courts or in the federal courts located in the State of
      Florida. The prevailing party shall be entitled to recover from the other party
      its reasonable attorney’s fees and costs.

    

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    17. MAILING
      OF NOTICES, ETC.
      All
      notices and other communications required or permitted hereunder shall be in
      writing and shall be deemed to have been duly given one (1) business day after
      delivery to an overnight carrier with instructions to deliver to the applicable
      address set forth below, or, if sent by facsimile, upon receipt of a
      confirmation of delivery: 

    

    Registered
      Holder: 

    

    To
      his or
      her last known address as indicated on the Company’s books and
      records.

    

    The
      Company:  

    Lifesciences
      Opportunities Incorporated

    8447
      Wilshire Blvd., Suite 102

    Beverly
      Hills, CA 90211

    Attention:
      Chief Executive Officer

     

    

    

    

    [Signature
      Page Follows]

    

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    IN
      WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly
      authorized officer as of ______________, 2008.

    

    

    
      	 	
              LIFESCIENCES
                OPPORTUNITIES INCORPORATED

              

              By: ______________________________

              Name:
                

              Title:
                 

            

    

    

    

    

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

     

    
      

      
        	 	
                
                  Notice
                    of Exercise

                  To
                    Be Executed by the Warrant Holder

                  In
                    Order to Exercise
                    Warrants

                

              

      

    

    

    TO:
      Lifesciences Opportunities Incorporated

    

    The
      undersigned hereby: (1) irrevocably subscribes for and offers to purchase
      __________ shares of common stock (“Warrant
      Shares”),
      of
      Lifesciences Opportunities Incorporated, pursuant to Warrant No. ___ heretofore
      issued to ___________________ dated _____________, 20____ and (2) encloses
      a
      cash payment of $__________ representing the aggregate exercise price for such
      Warrant Shares. 

    

    

    The
      undersigned hereby represents and warrants to the Company that it is an
“Accredited Investor” within the meaning of Rule 501 of Regulation D promulgated
      under the Securities Act of 1933, as amended (the “Securities
      Act”),
      and
      is acquiring these securities for its own account and not with a view to, or
      for
      sale in connection with, any distribution thereof, nor with any present
      intention of distributing or selling the same. The undersigned further
      represents that it does not have any contract, agreement, understanding or
      arrangement with any person to sell, transfer or grant the Warrant Shares
      issuable under this Warrant. The undersigned understands that the securities
      it
      will be receiving are “restricted securities” under Federal securities laws
      inasmuch as they are being acquired from Lifesciences Opportunities
      Incorporated, in transactions not including any public offering and that under
      such laws, such securities may only be sold pursuant to an effective and current
      registration statement under the Securities Act or an exemption from the
      registration requirements of the Securities Act and any other applicable
      restrictions, in which event a legend or legends will be placed upon the
      certificate(s) representing the Warrant Shares issuable under this Warrant
      denoting such restrictions. The undersigned understands and acknowledges that
      the Company will rely on the accuracy of these representations and warranties
      in
      issuing the securities underlying the Warrant.

    

    

    Date:  ________________________________________________________________________

    

    Warrant
      Holder Name: __________________________________________________________

    

    Taxpayer
      Identification Number: ____________________________________________________

    

    By:
      __________________________________________________________________________

    

    Printed
      Name: _________________________________________________________________

    

    Title:  ________________________________________________________________________

    

    Address:
       _____________________________________________________________________

     

    Note:
      The
      above signature should correspond exactly with the name on the face of this
      Warrant or with the name of assignee appearing in assignment form below.

    

    AND,
      if
      said number of Warrant Shares shall be less than the total number of Warrant
      Shares purchasable under the Warrant, a new Warrant is to be issued in the
      name
      of said undersigned for the balance remaining of the Warrant Shares purchasable
      thereunder less any fraction of a share of Common Stock paid in cash and
      delivered to the address stated above.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    ASSIGNMENT
      FORM

    To
      be
      executed by the Warrant Holder

    In
      order
      to Assign Warrants

    

    FOR
      VALUE
      RECEIVED,____________________________________ hereby sells, assigns and
      transfers unto

    

    PLEASE
      INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER

    

    
      	 

    

    

     

      
        

      

       

    

    
      
        

      

    

    (Please
      print or type name and address)

    

    

    ______________________
      of the Warrants represented by this Warrant, and hereby irrevocably constitutes
      and appoints ________________________ Attorney to transfer this Warrant on
      the
      books of the Company, with full power of substitution in the
      premises.

    

    Dated:______________________
       ____________________________

    (Signature
      of Registered Holder)

    

    

    In
      addition to executing this Assignment Form, the Warrant Holder and the
      transferee must comply with the other requirements for transfer set forth in
      Sections 6 and 7 of the Warrant.

    

    

    CERTIFICATION
      OF STATUS OF TRANSFEREE

    TO
      BE
      EXECUTED BY THE TRANSFEREE OF THIS WARRANT

    

    The
      undersigned transferee hereby certifies to the registered holder of this Warrant
      and to Lifesciences Opportunities Incorporated that the transferee is an
“accredited investor” within the meaning of Rule 501 of Regulation D promulgated
      under the Securities Act of 1933, as amended.

     

    

    
      	Dated:_____________________	__________________________

    

    
      	 	(Signature of
              Transferee)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]